Nordson Corporation
Analysis
Nordson turned from a flat industrial into a semiconductor-led grower this year: guidance went up every quarter and backlog is up 35% on AI chip capacity. Management's own plan has that slowing to mid-single digits next year.What did the last chip downcycle do to Nordson's sales and margins?
- Semiconductor demand is now the whole growth engine.
Advanced Technology's organic sales rose 31% in Q3 FY2026, with dispense and test-and-inspection both growing. Strip that out and the rest of the company grows about as it always has, so results now hang on chip makers' capacity spending.How much of the 35% backlog growth came from the semiconductor lines?
- Growth is arriving without much extra profit attached.
New sales converted to profit at about 31% this year, below the 35% to 40% management calls normal, as more of the mix was lower-margin systems in Asia. Medical also lost margin to a product changeover, so volume is outpacing profit.Which segment is furthest below its normal profit drop-through?
- The cash is being kept for a deal, not just buybacks.
Free cash flow has beaten net income five quarters running and leverage is down to 1.7x, below its own target. That leaves room to buy growth: CapstanAG was added at 9x earnings, and management says the deal pipeline is active.
- Semiconductor packaging demandThe bull case is that Nordson's dispensing and inspection tools sit inside chip packaging, so each new AI-driven capacity expansion pulls through equipment and spare parts.
- Order backlog visibilityOrder growth across all three segments has lifted backlog well above last year, giving management visibility it says turns into revenue within about six months.
- Medical growth returnsA medical business back to normal growth adds a second driver alongside chips, reducing reliance on one cyclical market to hit the full-year plan.
- Cyclical end market concentrationThe bear case is that the fastest growth now comes from one cyclical chip market near a peak, so today's growth rates do not carry into next year.
- Industrial segment growth limitsHalf the company sells into packaging, coatings and agriculture, where growth runs near GDP and the European and North American recovery has not yet shown up.
- Inflation squeezes incrementalsRising input and tariff costs mean Nordson is choosing between protecting margins and chasing volume, and profit on new sales has already narrowed.
| Politician | Transaction | Amount | Traded | Filed |
|---|---|---|---|---|
Donald Trump Republican · Executive | Purchase | ≥$15K | Mar 11 | May 13 |
Ro Khanna Democratic · House · CA-17 | Sale | ≥$15K | May 1 | Jun 9 |
Ro Khanna Democratic · House · CA-17 | Sale | ≥$1K | May 27 | Jun 9 |
Ro Khanna Democratic · House · CA-17 | Purchase | ≥$1K | Apr 15 | May 12 |
Ro Khanna Democratic · House · CA-17 | Purchase | ≥$1K | Apr 23 | May 12 |
Congressional trading data provided by QuiverQuant
How Nordson turned $2.7B of revenue into $674.0M of operating income.
| Revenue | ||
|---|---|---|
| Industrial Precision Solutions | $1.5B | ▲ 6.70% YoY |
| Medical And Fluid Solutions | $695.5M | ▲ 5.32% YoY |
| Advanced Technology Systems | $510.2M | ▼ 11.62% YoY |
| Total revenue | $2.7B | |
| Gross profit | $1.5B | 55.2% |
| Operating income | $674.0M | 25.1% |